|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
6 \' H* `2 D: o$ f8 I# {4 h" y' K01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.$ g! E1 I$ ^$ m2 y% } A
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.
& s, ?: S7 K" v- O& N03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.
: n$ I! G% t. p, H0 S- y, {4 ]) ?04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.+ s) W/ Z3 H5 F) y* ?8 S. U
05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.
) w* U6 Y) Z1 U5 z5 ~' m1 ]7 e06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.
1 w( J1 c: s4 y1 m8 ^& }07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.
% R3 i4 j/ Z& P7 [7 G) K7 [' z* F5 `08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.; E2 A- ^5 N5 s$ C9 \$ ]& E
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
: Y" `6 c& w0 s2 ]2 Q10.Interpretable machine learning for prostate biopsy: Cohort study.* T8 F6 c _/ i
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.; o. [( U: R/ m% ~8 A! n7 t
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.) W. a- q! S5 X% \
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).
- F4 |* ^" t: Y6 L( _14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).' r; ? v4 [/ W" X1 n# e
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
J( L3 f; [& [6 e! x: r16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
9 Q; d: s5 a8 U6 e9 L- g K17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.
2 Y/ b! [- B. n! D3 E- @' S18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.# N) b+ k3 }% C: g
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.2 ^- n$ p: ^* T7 z# Z: G. {5 m
20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
& P5 w5 a' X: _6 T& W2 h21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
* Z7 {8 I' x3 }- I" ~22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.* C- `) J/ K9 l% X* U( U
23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.) ]$ [0 u4 d8 E9 |8 D$ _
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.# j/ D# B; K/ |! H- k) q* m* p, I/ [
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.0 R* {# x3 w! N( {2 E, ]$ i+ f
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
